267 related articles for article (PubMed ID: 11020443)
1. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.
Kazanietz MG; Caloca MJ; Eroles P; Fujii T; García-Bermejo ML; Reilly M; Wang H
Biochem Pharmacol; 2000 Nov; 60(10):1417-24. PubMed ID: 11020443
[TBL] [Abstract][Full Text] [Related]
2. Novel "nonkinase" phorbol ester receptors: the C1 domain connection.
Kazanietz MG
Mol Pharmacol; 2002 Apr; 61(4):759-67. PubMed ID: 11901214
[TBL] [Abstract][Full Text] [Related]
3. New insights into the regulation of protein kinase C and novel phorbol ester receptors.
Ron D; Kazanietz MG
FASEB J; 1999 Oct; 13(13):1658-76. PubMed ID: 10506570
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications.
Kazanietz MG
Biochim Biophys Acta; 2005 Dec; 1754(1-2):296-304. PubMed ID: 16202672
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity.
Kazanietz MG; Lewin NE; Bruns JD; Blumberg PM
J Biol Chem; 1995 May; 270(18):10777-83. PubMed ID: 7537738
[TBL] [Abstract][Full Text] [Related]
6. Phorbol esters and related analogs regulate the subcellular localization of beta 2-chimaerin, a non-protein kinase C phorbol ester receptor.
Caloca MJ; Wang H; Delemos A; Wang S; Kazanietz MG
J Biol Chem; 2001 May; 276(21):18303-12. PubMed ID: 11278894
[TBL] [Abstract][Full Text] [Related]
7. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters.
Kazanietz MG
Mol Carcinog; 2000 May; 28(1):5-11. PubMed ID: 10820483
[TBL] [Abstract][Full Text] [Related]
8. C1 domains exposed: from diacylglycerol binding to protein-protein interactions.
Colón-González F; Kazanietz MG
Biochim Biophys Acta; 2006 Aug; 1761(8):827-37. PubMed ID: 16861033
[TBL] [Abstract][Full Text] [Related]
9. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters.
Brose N; Rosenmund C
J Cell Sci; 2002 Dec; 115(Pt 23):4399-411. PubMed ID: 12414987
[TBL] [Abstract][Full Text] [Related]
10. Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains.
Ananthanarayanan B; Stahelin RV; Digman MA; Cho W
J Biol Chem; 2003 Nov; 278(47):46886-94. PubMed ID: 12954613
[TBL] [Abstract][Full Text] [Related]
11. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
Rahman GM; Das J
J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138
[TBL] [Abstract][Full Text] [Related]
12. Phorbol esters modulate the Ras exchange factor RasGRP3.
Lorenzo PS; Kung JW; Bottorff DA; Garfield SH; Stone JC; Blumberg PM
Cancer Res; 2001 Feb; 61(3):943-9. PubMed ID: 11221888
[TBL] [Abstract][Full Text] [Related]
13. Chimaerins, novel non-protein kinase C phorbol ester receptors, associate with Tmp21-I (p23): evidence for a novel anchoring mechanism involving the chimaerin C1 domain.
Wang H; Kazanietz MG
J Biol Chem; 2002 Feb; 277(6):4541-50. PubMed ID: 11689559
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation.
Marquez C; Martinez C; Kroemer G; Bosca L
J Immunol; 1992 Oct; 149(8):2560-8. PubMed ID: 1401894
[TBL] [Abstract][Full Text] [Related]
15. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
Chen J; Deng F; Li J; Wang QJ
Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
[TBL] [Abstract][Full Text] [Related]
16. Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily.
Shao L; Lewin NE; Lorenzo PS; Hu Z; Enyedy IJ; Garfield SH; Stone JC; Marner FJ; Blumberg PM; Wang S
J Med Chem; 2001 Nov; 44(23):3872-80. PubMed ID: 11689073
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Rac-GAP (Rac-GTPase-activating protein) activity of beta2-chimaerin, a 'non-protein kinase C' phorbol ester receptor.
Caloca MJ; Wang H; Kazanietz MG
Biochem J; 2003 Oct; 375(Pt 2):313-21. PubMed ID: 12877655
[TBL] [Abstract][Full Text] [Related]
18. Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes.
Cooke M; Zhou X; Casado-Medrano V; Lopez-Haber C; Baker MJ; Garg R; Ann J; Lee J; Blumberg PM; Kazanietz MG
J Biol Chem; 2018 Jun; 293(22):8330-8341. PubMed ID: 29636415
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands.
Blumberg PM; Jaken S; König B; Sharkey NA; Leach KL; Jeng AY; Yeh E
Biochem Pharmacol; 1984 Mar; 33(6):933-40. PubMed ID: 6324806
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Calpha contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities.
Slater SJ; Ho C; Kelly MB; Larkin JD; Taddeo FJ; Yeager MD; Stubbs CD
J Biol Chem; 1996 Mar; 271(9):4627-31. PubMed ID: 8617724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
